SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

COURI, Carlos Eduardo Barra  and  VOLTARELLI, Júlio César. Potencial role of stem cell therapy in type 1 diabetes mellitus. Arq Bras Endocrinol Metab [online]. 2008, vol.52, n.2, pp. 407-415. ISSN 0004-2730.  http://dx.doi.org/10.1590/S0004-27302008000200029.

    1. Notkins AL, Lernmark A. Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest. 2001; 108:1247-52. [ Links ]

    2. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes. 1965;14:619-33. [ Links ]

    3. Matsumoto M, Yagi H, Kunimoto K, Kawaguchi J, Makino S, Harada M. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T-cell subsets in the pathogenesis. Cell Immunol. 1993;148:189-97. [ Links ]

    4. Li R, Perez N, Karumuthil-Melethil S, Vasu C. Bone Marrow Is a Preferential Homing Site for Autoreactive T-Cells in Type 1 Diabetes. Diabetes. 2007;56:2251-9. [ Links ]

    5. Pozzilli P, Di Mario U. Autoimune diabetes not requiring insulin at diagnosis (latent autoimune diabetes of the adult). Diabetes Care. 2001;24:1460-7. [ Links ]

    6. Petrone A, Galgani A, Spoletini M, Alemanno I, Di Cola S, Bassotti G, et al. Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype. Diabetes Metab Res Rev. 2005;21: 271-5. [ Links ]

    7. Pozzilli P, Mesturino CA, Crino A, Gross TM, Jeng LM, Visalli N; IMDIAB Group. Is the process of beta-cell destruction in type 1 diabetes at time of diagnosis more extensive in females than in males? Eur J Endocrinol. 2001; 145:757-61. [ Links ]

    8. Steele C, Hagopian WA, Gitelman S, Masharani U, Cavaghan M, Rother KI, et al. Insulin secretion in type 1 diabetes. Diabetes. 2004;53:426-33. [ Links ]

    9. The Epidemiology of Diabetes Interventions and Complications Research Group. The effect of intensive insulin therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002;287:2563-69. [ Links ]

    10. The Diabetes Control and Complications Trial Research Group Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the Diabetes Control and Complications Trial. Ann Intern Med. 1998;128:517-23. [ Links ]

    11. Swenne I. Pancreatic b-cell growth and diabetes mellitus. Diabetologia. 1992;35:193-201. [ Links ]

    12. Fernandes A, King LC, Guz Y, Stein R, Wright CV, Teitelman G. Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets. Endocrinology. 1997;138:1750-62. [ Links ]

    13. Bonner-Weir S, Sharma A. Pancreatic stem cell. J Pathol. 2002;197:519-26. [ Links ]

    14. Sako Y, Grill VE. Coupling of beta-cell desensitization by hyperglycemia to excessive stimulation and circulating insulin in glucose-infused rats. Diabetes. 1990;39:1580-3. [ Links ]

    15. Bernard C, Berthault MF, Saulnier C, Ktorza A. Neogenesis vs. apoptosis as main components of pancreatic beta-cell as changes in glucose-infused normal and mildly diabetic adult rats. FASEB J. 1999;13:1195-205. [ Links ]

    16. Bonner-Weir S, Deery D, Leahy JL, Weir GC. Compensatory growth of pancreatic b-cells in adult rats after short-term glucose infusion. Diabetes. 1989;38:49-53. [ Links ]

    17. Topp BG, McArthur MD, Finegood DT. Metabolic adaptations to chronic glucose infusion in rats. Diabetologia. 2004;47:1602-10. [ Links ]

    18. Bonner-Weir S, Trent DF, Weir GC. Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J Clin Invest. 1983;71:1544-53. [ Links ]

    19. Menge BA, Tannapfel A, Belyaev O, Drescher R, Müller C, Uhl W, et al. Partial pancreatectomy in adult humans does not provoke beta-cell regeneration. Diabetes. 2007; [Epub ahead of print& [ Links ]

    20. Kuroda A, Yamasaki Y, Imagawa A. b-cell Regeneration in a Patient with Type 1 Diabetes Mellitus Who Was Receiving Immunosuppressive Therapy. Ann Intern Med. 2003;139:81. [ Links ]

    21. Burns CJ, Persaud SJ, Jones PM. Stem cell therapy for diabetes: do we need to make beta-cells? J Endocrinol 2004;183:437-43. [ Links ]

    22. Couri CE, Foss MC, Voltarelli JC. Secondary prevention of type 1 diabetes mellitus: stopping immune destruction and promoting beta-cell regeneration. Braz J Med Biol Res. 2006;39:1271-80. [ Links ]

    23. Georgia S, Blushan A. b-cell replication is the primary mechanism of maintaining postnatal b-cell mass. J Clin Invest. 2004;114:963-8. [ Links ]

    24. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 2004;429:41-6. [ Links ]

    25. Nir T, Melton DA, Dor Y. Recovery from diabetes in mice by beta cell regeneration. J Clin Invest. 2007;117:2559-61. [ Links ]

    26. Seaberg R, Smukler SR, Kieffer TJ, et al. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol. 2004;22:1115-24. [ Links ]

    27. Bonner-Weir S, Taneja M, Weir GC, et al. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA. 2000;97:7999-8004. [ Links ]

    28. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult bone marrow. Nature. 2002;418:41-9. [ Links ]

    29. Chen LB, Jiang XB, Yang L. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol. 2004;10:3016-20. [ Links ]

    30. Lee RH, Seo MJ, Reger RL, et al. Multipotent stromal cells from human marrow home to promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci USA. 2006;103:17438-43. [ Links ]

    31. Urbán VS, Kiss J, Kovács J, et al. Mesenchymal Stem Cells Cooperate with Bone Marrow Cells in Therapy of Diabetes. Stem Cells 2007; Oct 11 [Epub ahead of print& [ Links ]

    32. Lagasse E, Connors H, Al-Dhalimy M et al. Purified hematopoietic stem cell can differentiate into hepatocytes in vivo. Nat Med. 2000;6:1229-34. [ Links ]

    33. Theise ND, Badve S, Saxena R, et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology. 2000;31:235-40. [ Links ]

    34. Kang EM, Zickler MM, Burns S et al. Hematopoietic stem cell transplantation prevents diabetes in NOD mice but does not contribute to significant islet cell regeneration once disease is established. Exp Hematol. 2005;33:699-705. [ Links ]

    35. Butler AE, Huang A, Rao PN, et al. Hematopoietic stem cells derived from adult donors are not a source of pancreatic-cells in adult nondiabetic humans. Diabetes. 2007;56:1810-16. [ Links ]

    36. Petersen BE, Goff JP, Greenberger JS, Michalopoulos GK. Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. Hepatology. 1998;27:433-5. [ Links ]

    37. Yang L, Li S, Hatch H, et al. In vitro transdifferentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci USA. 2002;99:8078-83. [ Links ]

    38. Kim S, Shin JS, Kim HJ, Fisher RC, Lee MJ, Kim CW. Streptozotocin-induced diabetes can be reversed by hepatic oval cell activation through hepatic transdifferentiation and pancreatic islet regeneration. Lab Invest. 2007;87:702-12. [ Links ]

    39. Kodama S, Kühtreiber W, Fujimura S, Dale EA, Faustman DL. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science. 2003;14:1223-7. [ Links ]

    40. Chong AS, Shen J, Tao J, Yin D, Kuznetsov A, Hara M, et al. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta-cell regeneration. Science. 2006;311:1774-5< [ Links ]

    41. Ende N, Chen R, Reddi AS. Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem Biophys Res Commun. 2004;325:665-9. [ Links ]

    42. Ende N, Chen R, Reddi AS. Transplantation of human umbilical cord blood cells improves glycemia and glomerular hypertrophy in type 2 diabetic mice. Biochem Biophys Res Commun. 2004;321:168-71. [ Links ]

    43. Naruse K, Hamada Y, Nakashima E, et al. Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes. 2005;54:1823-8. [ Links ]

    44. Yang L, Li S, Hatch H, et al. In vitro transdifferentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci USA 2002;99:8078-83. [ Links ]

    45. Kim S, Shin JS, Kim HJ, Fisher RC, Lee MJ, Kim CW. Streptozotocin-induced diabetes can be reversed by hepatic oval cell activation through hepatic transdifferentiation and pancreatic islet regeneration. Lab Invest. 2007;87:702-12. [ Links ]

    46. Yatoh S, Dodge R, Akashi T, Omer A, Sharma A, Weir GC, et al. Differentiation of affinity-purified human pancreatic duct cells to beta-cells. Diabetes. 2007;56:1802-9. [ Links ]

    47. Le Blanc K, Ringdén O. Mesenchymal stem cells: properties and role in clinical bone marrow transplantation. Curr Opin Immunol. 2006;18:586-91. [ Links ]

    48. Ryden M, Dicker A, Gotherstrom C, Astrom G, Tammik C, Arner P, et al. Functional characterization of human mesenchymal stem cell-derived adipocytes. Biochem Biophys Res Commun. 2003;311:391-7. [ Links ]

    49. Assady S, Maor G, Amit M, Itskovitzs-Eldor J, Skorecki KL, Tzukerman M. Insulin production by human embryonic stem cells. Diabetes. 2001;50:1691-7. [ Links ]

    50. Hansson M, Tonning A, Frandsen U, et al. Artifactual insulin release from differentiated embryonic stem cells. Diabetes. 2004;53:2603-9. [ Links ]

    51. Hughes IA. A perspective on stem cells by a clinician. Eur J Endocrinol. 2004;151:U3-5. [ Links ]

    52. Byrne JA, Pedersen DA, Clepper LL, Nelson M, Sanger WG, Gokhale S, et al. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature. 2007;450:497-502. [ Links ]

    53. Trucco M. Regeneration of the pancreatic b-cell. J Clin Invest. 2005;115:5-12. [ Links ]

    54. Voltarelli JC, Couri CEB, Stracieri ABPL, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA, 2007;297: 1568-76. [ Links ]

    55. Burt RK, Slavin S, Burns WH, Marmont AM. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: Getting closer to a cure? Blood. 2002;99:768-84. [ Links ]

    56. Haller MJ, Viener H, Brusko T, Wasserfall C, Mcgril K, Staba S, et al. Insulin requeirements, HbA1c, and stimulated C-peptide following autologous umbilical cord blood transfusion in children with T1D. American Diabetes Association 67th Scientific Sessions; 2007 June 22-26; Chicago. Alexandria: American Diabetes Association Publisher; 2007. A82 p. [ Links ]

    57. Tuma-Mubarak J, Fernandez-Viña R, Yalan AC, et al. Autologous bone marrow mononuclear cell (ABMMC) transplantation in type 1 and type 2 insulin-dependent diabetes mellitus patients. International Society of Cellular Therapy Meeting; 2007 June 24-27; Sydney. [ Links ]